Published in:

01-09-2000 | Original Articles

A prospective phase II trial of ONYX-015 adenovirus and chemotherapy in recurrent squamous cell carcinoma of the head and neck (the baylor experience)

Authors: Jeffery P. Lamont, MD, John Nemunaitis, MD, Joseph A. Kuhn, MD, Steven A. Landers, MD, Todd M. McCarty, MD

Published in: Annals of Surgical Oncology | Issue 8/2000